Skip to main content

Table 1 VTE incidence according to type of lymphoma

From: Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients

Lymphoma type

VTE n (%)

Indolent NHL

9/170 (5.3%)

Aggressive NHL

49/415 (11.8%)

SLL

1/2 (50%)

Hodgkin lymphoma

10/119 (8.4%)

  1. Legend: VTE venous thromboembolism, NHL non-Hodgkin lymphoma, SLL small lymphocytic lymphoma
Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us